ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 042

Mindfulness Matters: Early Insights from the Making Mindfulness Matter© in children with Juvenile Idiopathic Arthritis Study.

Roberta A Berard1, KAREN BEATTIE2, Sarah Wells3, Michelle Batthish4, Asha Jeyanathan5, Frances Montemurro6, Karen Bax7 and Andrea Knight8, 1London Health Sciences Centre, London, ON, Canada, 2McMaster University, Hamilton, ON, Canada, 3London Children's Hospital, ON, Canada, 4McMaster Children's Hospital, Hamilton, ON, Canada, 5Hospital for Sick Children, ON, Canada, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Adjunct Professor, Psychology, Western Ontario, ON, Canada, 8Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Abstracts: Juvenile Idiopathic Arthritis

Session Time: 5:29PM-5:34PM

Background/Purpose: Poor mental health (MH) in the pediatric rheumatology population has been shown to affect quality of life, educational attainment, and disease-related outcomes, such as medication adherence, healthcare utilization, and transition to adult care.  Although patients with juvenile idiopathic arthritis (JIA) represent the single largest disease group in pediatric rheumatology practice, there are gaps in our understanding of the co-morbid mental health effects in JIA, and in research on interventions to optimize MH for these patients. Preventive, skills-based approaches may strengthen coping and resilience, addressing the scarcity of pediatric MH resources. The Making Mindfulness Matter JIA (M3©-JIA) trial evaluates the feasibility, acceptability, and preliminary impact of an online mindfulness-based intervention in children with JIA and their caregivers.

Methods: M3©-JIA is a three-site, parallel, randomized controlled trial recruiting caregiver–child dyads (ages 4–12) into either an 8-week M3© intervention or wait-list control. Weekly online sessions are led by trained facilitators, with caregivers and children attending separate groups. The M3© program incorporates neuropsychology, social-emotional learning and positive psychology. Quantitative data include demographics, attendance, and pre-/post-intervention questionnaires assessing mindfulness and parenting practices; qualitative feedback was collected through open-text responses.

Results: Of 67 dyads screened to date, 22 (33%) were randomized (11 intervention, 11 control). Most caregivers were mothers (86%), mean age 40.6 ± 6.5 years. Children were predominantly female (82%) with a mean age at enrolment of 9.3 ± 2.7 years and disease duration of 5.3 ± 3.1 years. Attendance was higher among caregivers than children (≥80% session attendance: 75% vs. 50%), with strong engagement in both groups (camera on ≥85% of session: 75% vs. 88%).
Post-intervention, children reported greater awareness and use of mindfulness skills—for example, knowledge of “breathing breaks” increased from 42% to 100%, and understanding emotional regulation from 50% to 95%. Caregivers showed improvements in mindfulness and parenting confidence (e.g., practicing mindfulness regularly: 31% to 63%; confidence in helping their child calm down: 69% to 90%) (Table 1). Qualitative feedback highlighted enjoyment, connection, and the value of creative, hands-on activities.

Conclusion: Preliminary findings demonstrate that M3© is feasible, engaging, and positively received by children with JIA and their caregivers. Early data suggest improvements in mindfulness awareness and parenting practices. While primarily scheduling challenges limited randomization rates, strong adherence and satisfaction support the promise of M3© as a scalable mental health support strategy within JIA care.

Table 1 Participant demographics, adherence and satisfaction of the M3© program Supporting image 1


Disclosures: R. Berard: AbbVie/Abbott, 1, Celltrion, 12, advisory board; K. BEATTIE: None; S. Wells: None; M. Batthish: None; A. Jeyanathan: None; F. Montemurro: None; K. Bax: None; A. Knight: None.

To cite this abstract in AMA style:

Berard R, BEATTIE K, Wells S, Batthish M, Jeyanathan A, Montemurro F, Bax K, Knight A. Mindfulness Matters: Early Insights from the Making Mindfulness Matter© in children with Juvenile Idiopathic Arthritis Study. [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/mindfulness-matters-early-insights-from-the-making-mindfulness-matter-in-children-with-juvenile-idiopathic-arthritis-study/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mindfulness-matters-early-insights-from-the-making-mindfulness-matter-in-children-with-juvenile-idiopathic-arthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology